SYNKLINO A/S
CVR 38778676 · Public limited company (A/S) · Active · Medium risk
SYNKLINO A/S is a Public limited company (A/S), founded on , based in København K. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year.
Bankruptcy risk for SYNKLINO A/S
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38778676
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (9 years)
- Address
- Frederiksborggade 1, 2. th
1360 København K - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 680k
- Employees
- 3 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 8 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 34 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Avg. employees | 7 | 13 |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 148 | ||
| 1 Jan 2024 – 31 Dec 2024 | 191 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 170 | ||
| 1 Jan 2022 – 31 Dec 2022 | 143 | ||
| 1 Jan 2021 – 31 Dec 2021 | 173 | ||
| 1 Jan 2020 – 31 Dec 2020 | 179 | ||
| 1 Jan 2019 – 31 Dec 2019 | 185 | Late | |
| 7 Jul 2017 – 31 Dec 2018 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | John Sørensen Haurum | Current | |
| Board | Mette Marie Rosenkilde | Current | |
| Board | Morten Winther Schrøder | Current | |
| Board | Herwig-Ulf Johannes Richard Meier-Kriesche | Current | |
| Board | Mads Aage Laustsen | ||
| Board | Thomas Nitschke Kledal | ||
| Board | Mette Marie Rosenkilde | ||
| Board | Thomas Feldthus | ||
| Board | Lene Gerlach | ||
| Board | Gunnar Magnus Severus Modée Persson | ||
| Board | Mads Lacoppidan | ||
| Board | Christine Flarup Møller-Jensen | ||
| Owner (0%) | Mads Gravers Jeppesen | Current | |
| Owner (10%) | STRATEGIC INVESTMENTS A/S | Current | |
| Owner (5%) | MARIE RUDKJÆR SCHRØDER ApS | Current | |
| Owner (5%) | Winther Schrøder Holding ApS | Current | |
| Owner (33%) | Thomas Nitschke Kledal | ||
| Owner (33%) | Mette Marie Rosenkilde | ||
| Owner (25%) | Mads Gravers Jeppesen | ||
| Owner (33%) | TNK BIOTECH ApS | ||
| Owner (25%) | Mette Marie Rosenkilde | ||
| Owner (20%) | Mads Gravers Jeppesen | ||
| Owner (5%) | MR BIOINVEST ApS | ||
| Owner (33%) | TNK BIOTECH ApS | ||
| Owner (10%) | MR BIOINVEST ApS | ||
| Owner (5%) | Mette Marie Rosenkilde | ||
| Owner (5%) | VÆKSTFONDEN | ||
| Owner (15%) | MR BIOINVEST ApS | ||
| Owner (5%) | TNK BIOTECH ApS | ||
| Owner (5%) | STRATEGIC INVESTMENTS A/S | ||
| Owner (5%) | MARIE RUDKJÆR SCHRØDER ApS | ||
| Owner (5%) | Stichting Marcus Choleva Family Foundation | ||
| Owner (25%) | Maj Invest Minorities I K/S | ||
| Owner (5%) | Eir Ventures I AB | ||
| Owner (5%) | Danmarks Eksport- og Investeringsfond | ||
| Owner (0%) | Mette Marie Rosenkilde | ||
| Owner (0%) | TNK BIOTECH ApS | ||
| Owner (0%) | STRATEGIC INVESTMENTS A/S | ||
| Owner (33%) | SYNKLINO A/S | ||
| Owner (5%) | STRATEGIC INVESTMENTS A/S | ||
| Owner (10%) | STRATEGIC INVESTMENTS A/S | ||
| Owner (5%) | Winther Schrøder Holding ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Mette Marie Rosenkilde | Current | |
| Founder | Mads Gravers Jeppesen | Current | |
| Founder | TNK BIOTECH ApS | Current |
Address history (3 moves)
| Frederiksborggade 1, 2. th, 1360 København K | |
| Rådhusvej 13, 2920 Charlottenlund | |
| c/o Bioinnovation Institute, Ole Maaløes Vej 3, 2200 København N | |
| c/o Thomas N. Kledal, Asylgade 7A, 2800 Kgs. Lyngby |
Former names
| SYNKLINO A/S | – now |
| SYNKLINO ApS | – |
| SYNKLINO IVS | – |
Employees per year
Other companies at the same address
- Bryggens Ejendomsselskab A/S Bankrupt
- DOMO Komplementarselskab ApS Bankrupt
- FREDERIKSBORGGADE 1B P/S Bankrupt
- K/S MØRKHØJVEJ 500, SØBORG Bankrupt
- KOMPLEMENTAR VEJLE HOTEL ApS Bankrupt
- MØRKHØJVEJ 500, SØBORG 2006 ApS Bankrupt
- ASTRAL ApS Compulsorily dissolved
- BONNIERS BOGKLUBBER A/S Fusioneret
- Decisions ApS Active
- EFFEKTIV INCASSO ApS Opløst
- Entry Copenhagen ApS Opløst
- FORLAGET CENTRUM A/S Fusioneret
- Farumgade 2 B Holding ApS Fusioneret
- GASTRONOMISK INNOVATION KOMPLEMENTARSELSKAB ApS Opløst
- Go Autonomous ApS Active
- HANDELSSELSKABET AF 2. JANUAR 1992 ApS Fusioneret
- INVENSURE AKTUAR A/S Fusioneret
- INVENSURE II A/S Opløst
- INVENSURE PROJEKTRÅDGIVNING ApS Opløst
- INVENSURE REAL ESTATE A/S Opløst
- JYLLINGEVEJ, KØBENHAVN 2006 ApS Opløst
- L&R FAKTA A/S Fusioneret
- LINDHARDT OG RINGHOF FORLAG A/S Fusioneret
- MUSIKSELSKABET AF 11/2 1988 A/S Opløst
- NORCAP HOTELUDVIKLING ApS Opløst
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about SYNKLINO A/S
Has SYNKLINO A/S gone bankrupt?
No, SYNKLINO A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of SYNKLINO A/S?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the auditor of SYNKLINO A/S?
SYNKLINO A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was SYNKLINO A/S founded?
SYNKLINO A/S was founded on 7 July 2017.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.